Skip to main content

Indications for Mohs Micrographic Surgery

  • Chapter
  • First Online:
Mohs Micrographic Surgery

Abstract

Mohs micrographic surgery (MMS) can be used to treat a wide variety of tumors. General indications for Mohs micrographic surgery require that the cutaneous tumor be continuously growing. Additionally, MMS is considered particularly well suited for tumors that exhibit perineural invasion, tumors in high-risk anatomical areas, tumors that have been incompletely excised, and those with poorly defined clinical margins.

The indications for MMS for each tumor type can be divided into common and uncommon entities. The most common indications for MMS include Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Less common indications for MMS are not supported by as much evidence, but include: Dermato­fibrosarcoma Protuberans (DFSP), Microcystic Adnexal Carcinoma (MAC), Atypical Fibroxanthoma (AFX), Superficial Leiomyosarcoma, Malignant Fibrous Histiocytoma (MFH), Seba­ceous Carcinoma (SC), Melanoma, Merkel Cell Carcinoma (MCC), and Extramammary Paget’s Disease (EMPD). The evidence behind using Mohs micrographic surgery will be discussed for each entity as well as the relevant results from studies used to measure recurrence rates when using Mohs micrographic surgery for these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shriner DL, McCoy DK, Goldberg DJ, Wagner Jr RF. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39(1):79–97.

    Article  PubMed  CAS  Google Scholar 

  2. Steinman HK. Indications for Mohs surgery. In: Gross KG, Steinman HK, Rapini RP, editors. Mohs surgery fundamentals and techniques. St. Louis: Mosby Inc.; 1999. p. 9–14.

    Google Scholar 

  3. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 2001;76:1253–65.

    Article  PubMed  CAS  Google Scholar 

  4. Nouri K, Rivas MP. A primer of Mohs micrographic surgery: common indications. Skinmed. 2004;3(4):191–6.

    Article  PubMed  Google Scholar 

  5. Nouri K. What you need to know about Mohs micrographic surgery. Skin Aging. 2000;8:68–70.

    Google Scholar 

  6. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol. 1995;33(2):271–8.

    Article  PubMed  CAS  Google Scholar 

  7. Tulli A. Mohs micrographic surgery. In: Chu T, Chu AC, Edelson RL, editors. Malignant tumors of the skin. London: Arnold; 1999. p. 381–95.

    Google Scholar 

  8. Rowe DE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15:315–28.

    PubMed  CAS  Google Scholar 

  9. Rowe DE, Carroll RJ, Day CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15:424–31.

    PubMed  CAS  Google Scholar 

  10. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol. 1992;26:976–90.

    Article  PubMed  CAS  Google Scholar 

  11. Hansen JP, Drake AL, Walling HW. Bowen’s disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg. 2008;34(7):878–83.

    Article  PubMed  CAS  Google Scholar 

  12. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous carcinoma in situ (Bowen’s disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(6):997–1002.

    Article  PubMed  Google Scholar 

  13. Ratner D, Thomas CO, Johnson TM, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol. 1997;37(4):600–13.

    Article  PubMed  CAS  Google Scholar 

  14. Parker TL, Zitelli JA. Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1995;32(2 Pt 1):233–6.

    Article  PubMed  CAS  Google Scholar 

  15. Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the litertaure. Cancer. 2004;101(1):28–38.

    Article  PubMed  Google Scholar 

  16. Tom WD, Hybarger CP, Rasgon BM. Dermatofibrosarcoma protuberans of the head and neck: treatment with Mohs surgery using inverted horizontal paraffin sections. Laryngoscope. 2003;113:1289–93.

    Article  PubMed  Google Scholar 

  17. Dawes KW, Hanke CW. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical marings. Dermatol Surg. 1996;22:530–43.

    Article  PubMed  CAS  Google Scholar 

  18. Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol. 2001;44:656–9.

    Article  PubMed  CAS  Google Scholar 

  19. Ah-Weng A, Marsden JR, Sanders DS, Waters R. Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer. 2002;87(12):1386–9.

    Article  PubMed  CAS  Google Scholar 

  20. Wacker J, Khan-Durani B, Hartschuh W. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol. 2004;11:438–44.

    Article  PubMed  Google Scholar 

  21. Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol. 1994;20(10):687–9.

    PubMed  CAS  Google Scholar 

  22. Gloster Jr HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:82–7.

    Article  PubMed  Google Scholar 

  23. DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer. 2004;100(5):1008–16.

    Article  PubMed  Google Scholar 

  24. Meguerditchian A, Wang J, Lema B, Kraybill WG, Zeitouni NC, Kane JM. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol. 2010;33(2):300–3.

    PubMed  Google Scholar 

  25. Salerno S, Terril P. Will MAC be back? ANZ J Surg. 2003;73:830–2.

    Article  PubMed  Google Scholar 

  26. Snow S, Madjar Jr DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27(4):401–8.

    Article  PubMed  CAS  Google Scholar 

  27. Leibovitch I, Huilgol SC, Selva D, Lun K, Richards S, Paver R. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(2):295–300.

    Article  PubMed  Google Scholar 

  28. Bier-Lanning CM, Hom DB, Gapany M, Manivel JC, Duvall 3rd AJ. Microcystic adnexal carcinoma: management options based on long-term follow-up. Laryngoscope. 1995;105(11):1197–201.

    Article  Google Scholar 

  29. Carroll P, Goldstein GD, Brown CW. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg. 2000;26(6):531–4.

    Article  PubMed  CAS  Google Scholar 

  30. Cooper PH, MIlls SE, Leonard DD, SantaCruz DJ, Headington JT, Barr RJ. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol. 1985;9(6):422–33.

    Article  PubMed  CAS  Google Scholar 

  31. Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol. 1986;122:261–4.

    Article  PubMed  CAS  Google Scholar 

  32. Sebastien TS, Nelson BR, Lowe L, Baker S, Johnson TM. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1993;29:840–5.

    Article  PubMed  CAS  Google Scholar 

  33. Burns MK, Chen SP, Goldberg LH. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. J Dermatol Surg Oncol. 1994;20:429–34.

    PubMed  CAS  Google Scholar 

  34. Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41(2 Pt 1):225–31.

    Article  PubMed  CAS  Google Scholar 

  35. Chiller K, Passaro D, Scheuller M, Singer M, McCalmont T, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment and their outcome. Arch Dermatol. 2000;136:1355–9.

    Article  PubMed  CAS  Google Scholar 

  36. Abbate M, Zeitouni N, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg. 2003;29:1035–8.

    Article  PubMed  Google Scholar 

  37. Ang GC, Roenigk RK, Otley CC, Phillips PK, Weaver AL. More than 2 decades of treating atypical fibroxanthoma at Mayo Clinic: what have we learned from 91 patients? Dermatol Surg. 2009;35(5):765–72.

    Article  PubMed  CAS  Google Scholar 

  38. Huether MJ, Zitelli JA, Broadland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol. 2001;44:656–9.

    Article  PubMed  CAS  Google Scholar 

  39. Davis JL, Randle HW, Zalla MJ, Roenigk RK, Brodland DG. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg. 1997;23(2):105–10.

    Article  PubMed  Google Scholar 

  40. Nouri K, Rivas MP. A primer of Mohs micrographic surgery: uncommon indications. Skinmed. 2004;3(5):259–65.

    Article  PubMed  Google Scholar 

  41. Fields JP, Helwig EB. Leiomyosarcoma of the skin and subcutanous tissue. Cancer. 1981;47:156–69.

    Article  PubMed  CAS  Google Scholar 

  42. Humphreys TR, Finkelstein DH, Lee JB. Superficial leiomyosarcoma treated with Mohs micrographic surgery. Dermatol Surg. 2004;30:108–12.

    Article  PubMed  Google Scholar 

  43. Marcet S. Atypical fibroxanthoma/malignant fibrous histiocytoma. Dermatol Ther. 2008;21(6):424–7.

    Article  PubMed  Google Scholar 

  44. Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumors. Philadelphia: Mosby/Elsevier; 2008.

    Google Scholar 

  45. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer. 1986;57:368–76.

    Article  PubMed  CAS  Google Scholar 

  46. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13(2):113–22.

    Article  PubMed  CAS  Google Scholar 

  47. Berlin AL, Amin SP, Goldberg DJ. Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg. 2008;34:254–7.

    Article  PubMed  CAS  Google Scholar 

  48. Wick MR, Goellner JR, WolfeIII JT, Su WP. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer. 1985;56(5):1163–72.

    Article  PubMed  CAS  Google Scholar 

  49. Moreno C, Jacyk WK, Judd MJ, Requena L. Highly aggressive extraocular sebaceous carcinoma. Am J Dermatopathol. 2001;23(5):450–5.

    Article  PubMed  CAS  Google Scholar 

  50. Duman DG, Ceyhan BB, Celikel T, Duman RAD. Extraorbital sebaceous carcinoma with rapidly developing visceral metastases. Dermatol Surg. 2003;29(9):987–9.

    Article  PubMed  Google Scholar 

  51. Bassetto F, Baraziol R, Sottosanti MV, Scarpa C, Montesco M. Biological behavior of the sebaceous carcinoma of the head. Dermatol Surg. 2004;30(3):472–6.

    Article  PubMed  Google Scholar 

  52. Bouraoui S, Kaddar RK, Mokni M, Badri T, Azaiez MY, Dhahri AB. Extrapalpebral sebaceous carcinoma. Ann Dermatol Venereol. 2006;133(2):165–7.

    Article  PubMed  CAS  Google Scholar 

  53. Ni C, Searl S, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982;22(1):23–61.

    Article  PubMed  CAS  Google Scholar 

  54. Hassanein AM. Sebaceous carcinoma and the T-antigen. Semin Cutan Med Surg. 2004;23(1):62–72.

    Article  PubMed  Google Scholar 

  55. Doxanas MT, Green WR. Sebaceous gland carcinoma. Arch Ophthalmol. 1984;102:245–9.

    Article  PubMed  CAS  Google Scholar 

  56. Botek AA, Goldberg SH. Sebaceous gland carcinoma. In: Miller SJ, Maloney ME, editors. Cutaneous oncology. Malden: Blackwell Science Inc; 1998. p. 800–10.

    Google Scholar 

  57. Boniuk M, Zimmerman LE. Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968;27:619–42.

    Google Scholar 

  58. Spencer JM, Nossa R, Tse DT, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol. 2001;44:1004–9.

    Article  PubMed  CAS  Google Scholar 

  59. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37:236–45.

    Article  PubMed  CAS  Google Scholar 

  60. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH. Merkel cell carcinoma: analysis of clinical, histologic, and immunologic features of 132 cases with relation to survival. J Am Acad Dermatol. 1997;37(5 Pt 1):734–9.

    Article  PubMed  CAS  Google Scholar 

  61. O’Connor WJ, Broadland DG. Merkel cell carcinoma. Dermatol Surg. 1996;22(3):262–7.

    Article  PubMed  Google Scholar 

  62. Mercer D, Brander P, Liddell K. Merkel cell carcinoma: the clinical course. Ann Plast Surg. 1990;25:136–41.

    Article  PubMed  CAS  Google Scholar 

  63. O’Connor WJ, Roenigk RK, Broadland DG. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg. 1997;23(10):929–33.

    Article  PubMed  Google Scholar 

  64. Lee KY, Roh MR, Chung WG, Chung KY. Comparison of Mohs micrographis surgery and wide excision for extramammary Paget’s disease: Korean experience. Dermatol Surg. 2008;35:34–40.

    Article  PubMed  Google Scholar 

  65. O’Conner WJ, Lim KK, Zalla MJ, et al. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget’s disease. Dermatol Surg. 2003;29:723–7.

    Article  Google Scholar 

  66. Murata Y, Kumano K. Multicentricity of extramamary Paget’s disease. Eur J Dermatol. 2007;17(2):164–5.

    PubMed  Google Scholar 

  67. Gunn RA, Gallager HS. Vulvar Paget’s disease: a topographic study. Cancer. 1980;46:590–4.

    Article  PubMed  CAS  Google Scholar 

  68. Hendi A, Perdikis G, Snow JL. Unifocality of extramammary Paget disease. J Am Acad Dermatol. 2008;59:811–3.

    Article  PubMed  Google Scholar 

  69. Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget’s disease: a report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer. 1991;67:933–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keyvan Nouri .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

McLeod, M.P., Choudhary, S., Alqubaisy, Y.A., Nouri, K. (2012). Indications for Mohs Micrographic Surgery. In: Nouri, K. (eds) Mohs Micrographic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-2152-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2152-7_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2151-0

  • Online ISBN: 978-1-4471-2152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics